Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Share-based Compensation (2021 - 2025)

Biote has reported Share-based Compensation over the past 5 years, most recently at $2.2 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $2.2 million for Q4 2025, up 16.54% from a year ago — trailing twelve months through Dec 2025 was $8.5 million (up 104.98% YoY), and the annual figure for FY2025 was $8.9 million, up 2.13%.
  • Share-based Compensation for Q4 2025 was $2.2 million at Biote, down from $2.4 million in the prior quarter.
  • Over the last five years, Share-based Compensation for BTMD hit a ceiling of $2.4 million in Q3 2025 and a floor of $10000.0 in Q3 2024.
  • Median Share-based Compensation over the past 5 years was $1.1 million (2024), compared with a mean of $1.1 million.
  • Biggest five-year swings in Share-based Compensation: crashed 66.67% in 2024 and later soared 23900.0% in 2025.
  • Biote's Share-based Compensation stood at $138000.0 in 2021, then soared by 1468.12% to $2.2 million in 2022, then fell by 7.72% to $2.0 million in 2023, then dropped by 5.56% to $1.9 million in 2024, then increased by 16.54% to $2.2 million in 2025.
  • The last three reported values for Share-based Compensation were $2.2 million (Q4 2025), $2.4 million (Q3 2025), and $1.8 million (Q2 2025) per Business Quant data.